WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the introduction of legislation in the U.S. House by Reps. Suzan DelBene (D-Wash.), Jackie Walorski (R-Ind.),…

WASHINGTON, D.C. – A new analysis released today by the nonpartisan Tax Foundation reports that the return of the medical device excise tax would lead to a loss of 21,390 U.S. medical technology jobs…

WASHINGTON, D.C. – A coalition of major U.S. business groups is calling on Congress to repeal the medical device excise tax before it comes back into effect at the end of this…

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) is launching a suite of tools and resources – including online training, credentialing and certification – to aid implementation of its updated Code…

WASHINGTON, D.C. – As Congress prepares to address end-of-year spending decisions and other initiatives that are set to expire if not acted upon, the Advanced Medical Technology Association® (AdvaMed®) today released…

WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement today on CMS’s release of final CY 2020 Medicare payment rules…

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued a statement today from President and CEO Scott Whitaker regarding President Trump’s nomination of Dr. Stephen Hahn to serve as FDA Commissioner.

WASHINGTON, DC. – The Advanced Medical Technology Association® (AdvaMed®) was named one of the most effective trade associations in Washington, DC, according to the latest annual TradeMarks study released by…